মাল্যাশিয়া - ইংরেজি - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - folic acid; sodium ascorbate; nicotinamide; riboflavine sodium phosphate; biotin; thiamine mononitrate; cyanocobalamin; pyridoxine hydrochloride; sodium pantothenate -

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

fresenius kabi usa, llc - thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium anhydrous (unii: 957e53wv42) (riboflavin 5'-phosphate - unii:7n464ure7e), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), sodium pantothenate (unii: oes0r93f0c) (pantothenic ac - known hypersensitivity to any of the components, e.g. thiamine or methyl parahydroxybenzoate. soluvit n must not be given undiluted. when soluvit n is diluted with water based solutions, the admixture should be protected from light. this is not necessary if soluvit n is diluted with intralipid because of the protective effect of the fat emulsion. interference with clinical laboratory tests biotin may interfere with laboratory tests that are based on a biotin/streptavidin interaction, leading to either falsely decreased or falsely increased test results, depending on the assay. the risk of interference is higher in children and patients with renal impairment and increases with higher doses. when interpreting results of laboratory tests, possible biotin interference has to be taken into consideration, especially if a lack of coherence with the clinical presentation is observed (e.g. thyroid test results mimicking graves' disease in asymptomatic patients taking biotin or false negative troponin test results in p